# Moleculin Biotech (MBRX) — Earnings

MBRX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/mbrx/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$12.25 |
| EPS estimate | −$10.75 |
| EPS surprise | −13.95% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Aug 12, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1659617/000143774925026225/mbrx20250630_10q.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 12, 2025 | −$10.75 | −$12.25 | -13.95% | — | — |
| Q1 2025 | May 13, 2025 | −$13.88 | −$17.25 | -24.32% | — | — |
| Q4 2024 | Mar 21, 2025 | −$32.08 | $6.25 | 119.48% | — | — |
| Q3 2024 | Nov 8, 2024 | −$61.00 | −$71.25 | -16.80% | — | — |
| Q2 2024 | Aug 13, 2024 | −$62.75 | −$42.50 | 32.27% | — | — |
| Q1 2024 | May 10, 2024 | −$88.25 | −$50.50 | 42.78% | — | — |
| Q4 2023 | Mar 22, 2024 | −$80.63 | −$125.50 | -55.66% | — | — |
| Q3 2023 | Nov 13, 2023 | −$83.75 | −$71.25 | 14.93% | — | — |
| Q3 2022 | Nov 10, 2022 | −$103.75 | −$112.50 | -8.43% | — | — |
| Q1 2022 | May 11, 2022 | −$91.88 | −$90.00 | 2.04% | — | — |
| Q1 2021 | May 12, 2021 | −$86.25 | −$75.00 | 13.04% | — | — |
| Q4 2020 | Mar 24, 2021 | −$216.25 | −$90.00 | 58.38% | — | — |
| Q2 2020 | Aug 12, 2020 | −$202.50 | −$382.50 | -88.89% | — | — |
| Q1 2020 | May 11, 2020 | −$225.00 | −$45.00 | 80.00% | — | — |

## Frequently Asked Questions

### When did Moleculin Biotech (MBRX) last report earnings?

Moleculin Biotech last reported on Aug 12, 2025, covering fiscal Q2 2025.

### Did MBRX beat earnings estimates?

No. Moleculin Biotech reported EPS of −$12.25 for Q2 2025 against a −$10.75 estimate — a 13.95% miss.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).